NOE-105

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

A Double-blind, Placebo-controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients with Tourette Syndrome – Allevia 2